OR WAIT null SECS
December 18, 2018
The agency sent a warning letter to Cao Medical Equipment Co., Ltd. after inspectors found CGMP violations at the company’s Langfang, Hebei facility.
Asclemed USA Inc., dba Enovachem Pharmaceuticals is recalling the product due to labeling that incorrectly states that stoppers do not contain latex.
December 13, 2018
FDA has withdrawn the proposed rule that would have allowed generic-drug makers to independently update and distribute new safety information in drug labels.
December 12, 2018
New FDA guidance developed to identify lapses in data integrity and promote best practices.
FDA cites Zhejiang Huahai Pharmaceutical in valsartan impurity investigation.
December 05, 2018
Integration of two separate chromatography data systems boosts workflow efficiency.
December 02, 2018
A required time frame should not be the driving force behind root cause investigations, says Susan Schniepp, executive vice-president of Post-Approval Pharma and Distinguished Fellow, Regulatory Compliance Associates.
Microbial identity data can be critical for determining contamination sources.
Success depends on supplier communication and transparency, but it’s up to buyers to demand the right information and to look at the vendor’s overall business goals.
Simplified role-based training can lead to better quality metrics and compliance.